← FDA DRUG APPROVALS

FDA NDA · NDA050803

VELTIN

Sponsor: CHARTWELL RX

APPLICATION
NDA050803
TYPE
NDA
ORIGINAL APPROVAL
2010-07-16
LATEST ACTION
2010-07-16
ROUTE
TOPICAL
DOSAGE FORM
GEL
MARKETING STATUS
Prescription

Products

VELTIN · ReferencePrescription
CLINDAMYCIN PHOSPHATE 1.2%, TRETINOIN 0.025% · GEL · TOPICAL

Approval history

2010-07-16Type 5 - New Formulation or New Manufacturer · Original · standardLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →